NO20033683L - 2,4-disubstituerte pyrimidin-5-karboksamidderivater som KCNQ kaliumkanal modulatorer - Google Patents
2,4-disubstituerte pyrimidin-5-karboksamidderivater som KCNQ kaliumkanal modulatorerInfo
- Publication number
- NO20033683L NO20033683L NO20033683A NO20033683A NO20033683L NO 20033683 L NO20033683 L NO 20033683L NO 20033683 A NO20033683 A NO 20033683A NO 20033683 A NO20033683 A NO 20033683A NO 20033683 L NO20033683 L NO 20033683L
- Authority
- NO
- Norway
- Prior art keywords
- potassium channel
- channel modulators
- carboxamide derivatives
- kcnq potassium
- disubstituted pyrimidine
- Prior art date
Links
- 102000012359 KCNQ Potassium Channels Human genes 0.000 title 1
- 108010022282 KCNQ Potassium Channels Proteins 0.000 title 1
- QDXGKRWDQCEABB-UHFFFAOYSA-N pyrimidine-5-carboxamide Chemical class NC(=O)C1=CN=CN=C1 QDXGKRWDQCEABB-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26980001P | 2001-02-20 | 2001-02-20 | |
| PCT/US2002/004305 WO2002066036A1 (en) | 2001-02-20 | 2002-02-14 | 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20033683D0 NO20033683D0 (no) | 2003-08-19 |
| NO20033683L true NO20033683L (no) | 2003-10-17 |
Family
ID=23028698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20033683A NO20033683L (no) | 2001-02-20 | 2003-08-19 | 2,4-disubstituerte pyrimidin-5-karboksamidderivater som KCNQ kaliumkanal modulatorer |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20020183335A1 (cs) |
| EP (1) | EP1361879A1 (cs) |
| JP (1) | JP2005508833A (cs) |
| CA (1) | CA2438231A1 (cs) |
| CZ (1) | CZ20032233A3 (cs) |
| HU (1) | HUP0303841A2 (cs) |
| MX (1) | MXPA03007395A (cs) |
| NO (1) | NO20033683L (cs) |
| PL (1) | PL372944A1 (cs) |
| WO (1) | WO2002066036A1 (cs) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4460292B2 (ja) | 2001-10-17 | 2010-05-12 | ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | ピリミジン誘導体、これらの化合物を含む医薬組成物、その使用及びその調製方法 |
| EP1453516A2 (de) * | 2001-10-17 | 2004-09-08 | Boehringer Ingelheim Pharma GmbH & Co.KG | 5-substituierte 4-amino-2-phenylamino-pyrimdinderivate und ihre verwendung als beta-amyloid modulatoren |
| US7205307B2 (en) | 2002-02-14 | 2007-04-17 | Icagen, Inc. | Pyrimidines as novel openers of potassium ion channels |
| US7176310B1 (en) * | 2002-04-09 | 2007-02-13 | Ucb Sa | Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents |
| UY27939A1 (es) | 2002-08-21 | 2004-03-31 | Glaxo Group Ltd | Compuestos |
| ES2273077T3 (es) * | 2002-08-21 | 2007-05-01 | Glaxo Group Limited | Derivados de 2-fenilamino-4-trifluorometil-5 (bencil- o piridin-4-il-metil) carbamoilpirimidina como moduladores selectivos del receptor cannabinoide cb2. |
| US7459460B2 (en) * | 2003-05-28 | 2008-12-02 | Bristol-Myers Squibb Company | Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators |
| AR045010A1 (es) * | 2003-07-02 | 2005-10-12 | Vertex Pharma | Pirimidinas utiles como moduladores de canales ionicos cuya activacion es controlada por tension |
| JP5545690B2 (ja) * | 2003-12-01 | 2014-07-09 | クドス ファーマシューティカルズ リミテッド | 癌治療のためのｄｎａ損傷修復阻害剤 |
| GB0402356D0 (en) * | 2004-02-03 | 2004-03-10 | Glaxo Group Ltd | Novel compounds |
| GB0404105D0 (en) * | 2004-02-24 | 2004-03-31 | Glaxo Group Ltd | Novel compounds |
| TWI357901B (en) | 2004-03-12 | 2012-02-11 | Lundbeck & Co As H | Substituted morpholine and thiomorpholine derivati |
| JP2007532669A (ja) | 2004-04-13 | 2007-11-15 | イカジェン インコーポレイテッド | カリウムイオンチャネル調節剤としての多環式ピリミジン |
| JP5008569B2 (ja) * | 2004-10-22 | 2012-08-22 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Ｃ−ｆｍｓキナーゼのインヒビターとしての芳香族アミド |
| JP2008519034A (ja) * | 2004-11-03 | 2008-06-05 | バーテックス ファーマシューティカルズ インコーポレイテッド | イオンチャネル調節剤としてのピリミジン誘導体および使用方法 |
| CA2599890C (en) * | 2005-03-03 | 2011-05-03 | H. Lundbeck A/S | Substituted pyridine derivatives |
| UA92340C2 (en) * | 2005-03-03 | 2010-10-25 | Х. Луннбек А/С | Substituted pyridine derivatives |
| JP2008534472A (ja) * | 2005-03-22 | 2008-08-28 | ノイロサーチ アクティーゼルスカブ | カリウムチャンネル調節剤としてのピラゾリル−ピリミジン及びその医学的使用 |
| DE102005038947A1 (de) * | 2005-05-18 | 2006-11-30 | Grünenthal GmbH | Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln |
| JP5388574B2 (ja) * | 2005-05-31 | 2014-01-15 | バーテックス ファーマシューティカルズ インコーポレイテッド | イオンチャネルのモジュレーターとして有用なヘテロ環式類 |
| US7683058B2 (en) | 2005-09-09 | 2010-03-23 | H. Lundbeck A/S | Substituted pyrimidine derivatives |
| CN101258133A (zh) * | 2005-09-09 | 2008-09-03 | H.隆德贝克有限公司 | 嘧啶衍生物和它们作为kcnq钾通道开放剂的用途 |
| EP2132196A1 (en) | 2007-02-26 | 2009-12-16 | Pfizer Products Inc. | Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
| ES2524883T3 (es) * | 2008-03-18 | 2014-12-15 | Merck Sharp & Dohme Corp. | 4-Hidroxipirimidina-5-carboxamidas sustituidas |
| TWI504395B (zh) | 2009-03-10 | 2015-10-21 | Substituted 3-amino-2-mercaptoquinoline as a KCNQ2 / 3 modifier | |
| TWI461197B (zh) | 2009-03-12 | 2014-11-21 | 2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier | |
| TWI475020B (zh) * | 2009-03-12 | 2015-03-01 | The substituted nicotine amide as a KCNQ2 / 3 modifier | |
| TW201038565A (en) | 2009-03-12 | 2010-11-01 | Gruenenthal Gmbh | Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators |
| US8883812B2 (en) * | 2010-07-08 | 2014-11-11 | Pfizer Inc. | Piperidinyl pyrimidine amides as Kv7 potassium channel openers |
| US8653101B2 (en) | 2010-08-27 | 2014-02-18 | Gruenenthal Gmbh | Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators |
| WO2012025237A1 (en) | 2010-08-27 | 2012-03-01 | Grünenthal GmbH | Substituted 2-amino-quinoline-3-carboxamides as kcnq2/3 modulators |
| ES2537615T3 (es) | 2010-08-27 | 2015-06-10 | Grünenthal GmbH | 2-Oxo- y 2-tioxo-dihidroquinolina-3-carboxamidas sustituidas como moduladores de KCNQ2/3 |
| EP2611780A1 (en) | 2010-09-01 | 2013-07-10 | Grünenthal GmbH | Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as kcnq2/3 modulators |
| US8552200B2 (en) | 2010-10-20 | 2013-10-08 | Gruenenthal Gmbh | Substituted 6-amino-nicotinamides as KCNQ2/3 modulators |
| US9168259B2 (en) | 2010-10-20 | 2015-10-27 | Grünenthal GmbH | Substituted 6-amino-nicotinamides as KCNQ2/3 modulators |
| CA2870573A1 (en) | 2012-04-18 | 2013-10-24 | Grunenthal Gmbh | Substituted 6-amino-nicotinamides bearing an oh-containing group as kcnq2/3 modulators |
| EP2844645A1 (en) | 2012-04-18 | 2015-03-11 | Grünenthal GmbH | Substituted 4-aminobenzamides as kcnq2/3 modulators |
| JP2016508960A (ja) | 2012-11-28 | 2016-03-24 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | Ｋｃｎｑ２／３モジュレーターとしての特定のカルボキサミド |
| WO2014082739A1 (en) * | 2012-11-28 | 2014-06-05 | Grünenthal GmbH | Substituted amino-arylcarboxamides as kcnq2/3 modulators |
| US9248122B2 (en) | 2012-11-28 | 2016-02-02 | Grünenthal GmbH | Heteroquinoline-3-carboxamides as KCNQ2/3 modulators |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5935966A (en) * | 1995-09-01 | 1999-08-10 | Signal Pharmaceuticals, Inc. | Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions |
| US5852028A (en) * | 1995-12-18 | 1998-12-22 | Signal Pharmaceuticals, Inc. | Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions |
| US5811428A (en) * | 1995-12-18 | 1998-09-22 | Signal Pharmaceuticals, Inc. | Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions |
| US6274588B1 (en) * | 1999-05-31 | 2001-08-14 | Hoffmann-La Roche Inc. | 4-phenyl-pyrimidine derivatives |
| JP2003506388A (ja) * | 1999-08-04 | 2003-02-18 | アイカゲン インコーポレイテッド | 疼痛および不安症を処置または予防するための方法 |
| CA2438868A1 (en) * | 2001-02-20 | 2002-09-19 | Valentin K. Gribkoff | Modulators of kcnq potassium channels and use thereof in treating migraine and mechanistically related diseases |
-
2002
- 2002-02-14 JP JP2002565594A patent/JP2005508833A/ja active Pending
- 2002-02-14 US US10/075,521 patent/US20020183335A1/en not_active Abandoned
- 2002-02-14 MX MXPA03007395A patent/MXPA03007395A/es unknown
- 2002-02-14 HU HU0303841A patent/HUP0303841A2/hu unknown
- 2002-02-14 CA CA002438231A patent/CA2438231A1/en not_active Abandoned
- 2002-02-14 EP EP02709517A patent/EP1361879A1/en not_active Withdrawn
- 2002-02-14 CZ CZ20032233A patent/CZ20032233A3/cs unknown
- 2002-02-14 PL PL02372944A patent/PL372944A1/xx not_active Application Discontinuation
- 2002-02-14 WO PCT/US2002/004305 patent/WO2002066036A1/en not_active Ceased
-
2003
- 2003-08-19 NO NO20033683A patent/NO20033683L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA03007395A (es) | 2003-12-04 |
| JP2005508833A (ja) | 2005-04-07 |
| WO2002066036A1 (en) | 2002-08-29 |
| US20020183335A1 (en) | 2002-12-05 |
| NO20033683D0 (no) | 2003-08-19 |
| EP1361879A1 (en) | 2003-11-19 |
| CA2438231A1 (en) | 2002-08-29 |
| HUP0303841A2 (hu) | 2004-03-01 |
| CZ20032233A3 (cs) | 2004-12-15 |
| PL372944A1 (en) | 2005-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20033683L (no) | 2,4-disubstituerte pyrimidin-5-karboksamidderivater som KCNQ kaliumkanal modulatorer | |
| NO20012739L (no) | 3-substituerte-4-arylquinolin-2-on-derivater som kaliumkanal modulatorer | |
| DK1446394T3 (da) | Hidtil ukendte 1,2,4-thiadiazolderivater som melanocortinreceptormodulatorer | |
| CY2014041I2 (el) | 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια | |
| NO20035245D0 (no) | Grunnleggende Wi-Fi-arkitektur for 802.11-nettverk | |
| NO20034930D0 (no) | Substituerte cykloheksan-1,4-diaminderivater | |
| NO20022649D0 (no) | Heterocykliske dihydropyrimidiner som kaliumkanal inhibitorer | |
| DK1593670T3 (da) | Hydroxysubstituerede 2-azetidinoner, der er anvendelige som hypokolesterolæmiske midler | |
| NO20052995D0 (no) | 1,5-diaryl-pyrrol-3-karboksamid-derivater, og deres anvendelse som kannabinoid reseptormodulatorer. | |
| ATE323706T1 (de) | Pyrazolopyridazinderivate | |
| NO20040632L (no) | 2-amino-4,5-trisubstituerte tiazolylderivater. | |
| NO20033353L (no) | Karotenoid biosyntese | |
| DK1429607T3 (da) | Delta-1-pyrroliner som pesticider | |
| DE60210598D1 (de) | 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA | |
| DK1330458T3 (da) | N-(1,2,4-triazoloazinyl)thiophensulfonamidforbindelser som herbicider | |
| NO20033234L (no) | Karotenoider som antihypertensjonsmidler | |
| NO20005570D0 (no) | Cyklopentanondihydropyridinforbindelser anvendbare som kaliumkanalÕpnere | |
| NO20044413L (no) | 1,2-Dihydropyrazol-3-oner som cytokinmediatorer | |
| DE60213084D1 (de) | 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA | |
| ITMI20022183A1 (it) | Cerniera. | |
| DK1349850T3 (da) | Natriumkanalmodulatorer, der er afledt af 2-piperidylimidazoler | |
| ITTO20020747A1 (it) | Composizione. | |
| DK1487802T3 (da) | 2,3-diaryl-pyrazolidin-derivater som neurotensin-nedbrydende enzyminhibitorer | |
| HK1057483A (en) | 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators | |
| EP1559708A4 (en) | 2,2-DISUBSTITUTED 1A, 25-DIHYDROXY-19-NORVITAMINE D DERIVATIVE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |